Invitrogen™ Human LYRM1 Synthetic Peptide

Ref.: BL-RE-176467Manufacturer ref.: PEP-1034 50 μg
€149.00 excl. VAT

LYRM1 Synthetic Peptide, PEP-1034, from Invitrogen.

Gene ID (Enter)
57149
Species
Human
Purification method
Purified
Accession number
O43325
Common name
Human LYRM1
Brand
Invitrogen

LYRM1 Synthetic Peptide, PEP-1034, from Invitrogen.

LYRM1 Synthetic Peptide, PEP-1034, from Invitrogen.

LYRM1 was one of many genes identified through a suppression subtractive hybridization comparing their expression in omental adipose tissue of obese patients compared to non-obese individuals. Further study confirms that both mRNA and protein levels of LYRM1 are higher in obese individuals. LYRM1 is widely expressed, with highest levels occurring in adipose and liver tissues. It is thought that LYRM1 promotes preadipocyte proliferation and can inhibit apoptosis of preadipocytes. Ectopic LYRM1 expression did not significantly affect adipogenesis, suggesting that LYRM1 can influence adipose tissue homeostasis by modulating the size of the preadipocyte pool.

Species

Species: Human.

Conservation

Storage: -20°C.

Formulation

Concentration: 200 μg/mL.

Regulatory status

Research only (RUO).

Packaging

Packaging: 50 μg.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15215039
Specifications
Gene ID (Enter)57149
SpeciesHuman
Purification methodPurified
Accession numberO43325
Common nameHuman LYRM1
Concentration200 μg/mL
DescriptionSynthetic Peptide
FormatLiquid
FormulaPBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
For use with (application)Blocking Assay, Control
Gene symbol(s)LYRM1
LyophilizedNo
Product typePeptide
Quantity50 μg
Regulatory statusRUO - research use only
Storage and shipping
Content and storage-20°C
Conservative0.02% sodium azide
Storage stampPBS

Origin and customs

Manufacturer ref.PEP-1034
Country of originUnited States
HS customs code3824 99 92 00
A question or a specific configuration?
Contact us for a quote.